S Brown, MD
Anesthesiology · Phoenix, AZNPI 1336118637
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $20,000 of the $21,822 with a category attached, or 91.6%. AbbVie accounts for 95.0% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2021 at $15,460 and has fallen 99.9% since, to $14 in 2025. Among anesthesiology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 63 payments — averaging $346.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$21K
- Merz North America, Inc.$435
- Takeda Pharmaceuticals U.S.A., Inc.$119
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$112
- QOL Medical, LLC$100
- Ardelyx, Inc.$80
- plus $252 from 8 others
What the payments were for
- Speaking & faculty fees$20,00092%
- Food & beverage$1,8228%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 23 | $20,725 |
| Merz North America, Inc. | 8 | $435 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $119 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $112 |
| QOL Medical, LLC | 3 | $100 |
| Ardelyx, Inc. | 4 | $80 |
| Daiichi Sankyo Inc. | 3 | $79 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
| Galderma Laboratories, L.p. | 2 | $34 |
| Braintree Laboratories, Inc. | 2 | $29 |
| Lilly USA, LLC | 1 | $24 |
| Merck | 1 | $22 |
| Boehringer Ingelheim | 1 | $14 |
| Celltrion USA Inc. | 1 | $14 |
How this compares
$21,822 in reported general payments places this provider in the 95th percentile of 1,166 anesthesiology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anesthesiology in Phoenix
- Neil GreenPhoenix$22K
- Delbert BlackPhoenix$11K
- Masoud SultaniPhoenix$11K
- Christopher WiePhoenix$10K
- Roy O'NeilPhoenix$10K
- John WallacePhoenix$8K
- Ryan HuffmanPhoenix$7K
- Brigitte FlanaganPhoenix$7K
- Brandon MinzerPhoenix$7K
- Mark MathewsPhoenix$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.